Venous Thromboembolism
Conditions
Keywords
Clonal Hematopoiesis of indeterminate potential
Brief summary
The aim of the study is to investigate the existence of clonal hematopoiesis of indeterminate potential (CHIP) in patients with a history of venous thromboembolism. The study investigators make the assumption that these patients present mutations involved in CHIP occurrence.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Men and women over 50 years old who have consulted at the Hematology laboratory of the Nîmes University Hospital for the occurrence or history of venous thromboembolism * Patient who has accepted that their DNA was kept and used in the context of research on venous thromboembolism (biobank (registration number DC-2008-290 and authorization number AC-2008-107))
Exclusion criteria
* Patients less than 50 years old * Patient who has refused that their DNA was kept and used in the context of research on venous thromboembolism
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| DNMT3A mutations screening | For sequencing analysis: 2 months | Next generation sequencing |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| TET2, ASXL1, TP53, JAK2, SF3B1, SRSF2, GNB1, CBL, BCOR, SH2B3, PPM1D mutations screening | For sequencing analysis: 2 months | Next generation sequencing |
Countries
France